In this episode, futurist Trond Arne Undheim interviews Greg Licholai, Chief Medical Officer, PRA Health Sciences, Faculty at Yale School of Management, and healthcare innovation columnist for Forbes. We talk about where digital health as a field is righ...
In this episode, futurist Trond Arne Undheim interviews Greg Licholai, Chief Medical Officer, PRA Health Sciences, Faculty at Yale School of Management, and healthcare innovation columnist for Forbes. We talk about where digital health as a field is right now and where it’s moving, promising startups, vaccine innovation, improving clinical trials and staying ahead by tracking insight in the field.
After listening, check out PRA Health Sciences as well as Greg Licholai's online profile:
The takeaway is that digital health has come quite far, but that its breakaway promises have only just begun to manifest themselves. This year, investment in the field has spiked, even before COVID-19, which indicates we will move at a rapid pace in the next few years. One exciting field is prescription digital therapeutics. However, big challenges remain. Progress in healthcare doesn’t come easy, even with digital tools at our disposal. We are dealing with legacy infrastructures, mindsets, government regulation and intractable problems coming from left field, such as pandemics and the complexities inherent in any public health intervention.
Additional context about the show, the topics, and our guests, including show notes and a full list of podcast players that syndicate the show can be found at https://trondundheim.com/podcast/.
For more about the host, including media coverage, books and more, see:
To advertise or become a guest on the show, contact the podcast host here. If you like the show, please tell all your friends, subscribe and consider rating it five stars. The show is hosted by Podbean and can be found at Futurized.co. The intro/outro music is Electricity by Ian Post from the album Magnetism.
Chief Medical and Information Officer, PRA Health Sciences & Co-director, Yale Center for Digital Health
Greg teaches at Yale School of Management, is Co-Director of the Center for Digital Health and contributes to Forbes. He is Chief Medical and Information Officer at PRA Health Sciences, a leading pharmaceutical service, healthcare data and contract research provider. Previously, he was President of the rare disease at Moderna Therapeutics; President and Chief Medical Officer at Castle Creek Pharmaceuticals and was a partner at McKinsey & Co. where he ran the healthcare data service line. He was also a senior executive at Proteostasis, Amicus Therapeutics and Medtronic Neurological as well as venture investor for Domain Associates. He was co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University and Boston College. He trained at the Brigham and Women’s, Children’s, and Massachusetts General Hospitals. He serves on multiple company and non-profit boards including advisor to the Clinical Trials Transformation Initiative (CTTI), a public private partnership co-founded by Duke University and the Food and Drug Administration (FDA). He writes about innovation in healthcare for Forbes.